Journal of clinical medicine
Comparative Longitudinal Evaluation of Systemic Inflammatory Markers in Type 2 Diabetes Treated with Four Oral Antidiabetic Drug Classes.
Mehmet Yamak, Serkan Çakır, Sami Uzun, Egemen Cebeci, Özlem Menken, Savas Ozturk
Published: 202610.3390/jcm15020688
Abstract
Background: Systemic inflammation plays a central role in the pathogenesis and progression of type 2 diabetes mellitus (T2DM). Hematologic inflammatory indices-such as the Systemic Immune-Inflammation Index (SII), Neutrophil-to-Lymphocyte Ratio (NLR)…
Preview only. Read the full abstract at the source